Clinical Trial Update: Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of recombinant protein-free factor VIII (rAHF-PFM) in previously untreated Hemophilia A patients; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rAHF-PFM (recombinant protein-free manufactured factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2011-07-15